- Home
- CHRS vs HAIN Comparison
CHRS vs HAIN Comparison
Compare CHRS & HAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- HAIN
- Stock Information
- Founded
- CHRS 2010
- HAIN 1993
- Country
- CHRS United States
- HAIN United States
- Employees
- CHRS N/A
- HAIN N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- HAIN Packaged Foods
- Sector
- CHRS Health Care
- HAIN Consumer Staples
- Exchange
- CHRS Nasdaq
- HAIN Nasdaq
- Market Cap
- CHRS 159.2M
- HAIN 159.7M
- IPO Year
- CHRS 2014
- HAIN 1993
- Fundamental
- Price
- CHRS $1.35
- HAIN $1.44
- Analyst Decision
- CHRS Strong Buy
- HAIN Hold
- Analyst Count
- CHRS 4
- HAIN 10
- Target Price
- CHRS $4.51
- HAIN $3.48
- AVG Volume (30 Days)
- CHRS 1.2M
- HAIN 1.9M
- Earning Date
- CHRS 11-05-2025
- HAIN 09-15-2025
- Dividend Yield
- CHRS N/A
- HAIN N/A
- EPS Growth
- CHRS N/A
- HAIN N/A
- EPS
- CHRS 1.55
- HAIN N/A
- Revenue
- CHRS $272,209,000.00
- HAIN $1,559,780,000.00
- Revenue This Year
- CHRS N/A
- HAIN $0.33
- Revenue Next Year
- CHRS $109.48
- HAIN $1.02
- P/E Ratio
- CHRS $0.87
- HAIN N/A
- Revenue Growth
- CHRS 52.33
- HAIN N/A
- 52 Week Low
- CHRS $0.66
- HAIN $1.30
- 52 Week High
- CHRS $2.43
- HAIN $9.43
- Technical
- Relative Strength Index (RSI)
- CHRS 64.99
- HAIN 34.80
- Support Level
- CHRS $1.23
- HAIN $1.42
- Resistance Level
- CHRS $1.40
- HAIN $2.17
- Average True Range (ATR)
- CHRS 0.08
- HAIN 0.13
- MACD
- CHRS -0.00
- HAIN -0.05
- Stochastic Oscillator
- CHRS 72.13
- HAIN 2.67
About CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.
About HAIN Hain Celestial Group Inc. (The)
The Hain Celestial Group Inc is a health and wellness company. It makes natural and organic food and personal-care products. The company offers products across various categories such as snacks, baby & kids food, beverages, meal preparation, and personal care through brands like Garden Veggie Snacks, Terra chips, Garden of Eatin snacks, Hartley's Jelly, and Celestial Seasonings teas among others. It operates under two reportable segments; North America and International. The majority of its revenue is derived from the North America segment which represents the sale of its products in the United States and Canada. The International segment includes the sale of its products in the United Kingdom and the Western European region.